Toward a new age of cellular pharmacokinetics in drug discovery

References

• Altan, N., Chen, Y., Schindler, M., Simon, S. M. (1998). Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 187:1583–1598.
   PubMed Web of Science ®Google Scholar
• Argov, M., Bod, T., Batra, S., Margalit, R. (2010). Novel steroid carbamates reverse multidrug-resistance in cancer therapy and show linkage among efficacy, loci of drug action, and P-glycoprotein’s cellular localization. Eur J Pharm Sci 41:53–59.
   PubMed Web of Science ®Google Scholar
• Armstrong, J. A., Hart, P. D. (1971). Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 134:713–740.
   PubMed Web of Science ®Google Scholar
• Baldini, N., Scotlandi, K., Serra, M., Shikita, T., Zini, N., Ognibene, A., et al. (1995). Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur J Cell Biol 68:226–239.
   PubMed Web of Science ®Google Scholar
• Barcia-Macay, M., Mouaden, F., Mingeot-Leclercq, M. P., Tulkens, P. M., Van Bambeke, F. (2008). Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts). J Antimicrob Chemother 61:1288–1294.
   PubMed Web of Science ®Google Scholar
• Both, G. W. (2009). Gene-directed enzyme prodrug therapy for cancer: a glimpse into the future? Discov Med 8:97–103.
   PubMedGoogle Scholar
• Bour-Dill, C., Gramain, M. P., Merlin, J. L., Marchal, S., Guillemin, F. (2000). Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug resistant MCF-7 cells using fluorescence microscopy image analysis. Cytometry 39:16–25.
   PubMedGoogle Scholar
• Carcaboso, A. M., Elmeliegy, M. A., Shen, J., Juel, S. J., Zhang, Z. M., Calabrese, C., et al. (2010). Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas. Cancer Res 70:4499–4508.
   PubMed Web of Science ®Google Scholar
• Chintagumpala, M. M., Friedman, H. S., Stewart, C. F., Kepner, J., McLendon, R. E., Modrich, P. L., et al. (2006). A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children’s oncology group. J Neurooncol 77:193–198.
   PubMed Web of Science ®Google Scholar
• Chanteux, H., Mingeot-Leclercq, M. P., Sonveaux, E., Van Bambeke, F., Tulkens, P. M. (2003). Intracellular accumulation and activity of ampicillin used as free drug and as its phthalimidomethyl or pivaloyloxymethyl ester (pivampicillin) against Listeria monocytogenes in J774 macrophages. J Antimicrob Chemother 52:610–615.
   PubMed Web of Science ®Google Scholar
• Chen, L. B. (1989). Fluorescent labeling of mitochondria. Meth Cell Biol 29:103–123.
   PubMed Web of Science ®Google Scholar
• Ciaparrone, M., Quirino, M., Schinzari, G., Zannoni, G., Corsi, D. C., Vecchio, F. M., et al. (2006). Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Oncology 70:366–377.
   PubMed Web of Science ®Google Scholar
• De Milito, A., Fais, S. (2005). Proton pump inhibitors may reduce tumour resistance. Exp Opin Pharmacother 6:1049–1054.
   PubMed Web of Science ®Google Scholar
• DiMasi, J. A. (1995). Success rates for new drugs entering clinical testing in the United States. Clin Pharmacol Ther 58:1–14.
   PubMed Web of Science ®Google Scholar
• Duvvuri, M., Krise, J. P. (2005). Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review. Front Biosci 10:1499–1509.
   PubMed Web of Science ®Google Scholar
• Eloranta, J. J., Meier, P. J., Kullak-Ublick, G. A. (2005). Coordinate transcriptional regulation of transport and metabolism. Meth Enzymol 40:511–530.
   Google Scholar
• Gandhi, V., Kantarjian, H., Faderl, S., Bonate, P., Du, M., Ayres, M., et al. (2003). Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias. Clin Cancer Res 9:6335–6342.
   PubMed Web of Science ®Google Scholar
• Gong, Y., Duvvuri, M., Krise, J. P. (2003). Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60. J Biol Chem 278:50234–50239.
   PubMed Web of Science ®Google Scholar
• Gong, Y., Wang, Y., Chen, F., Han, J., Miao, J., Shao, N., et al. (2000). Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line. Leuk Res 24:769–774.
   PubMed Web of Science ®Google Scholar
• Gotttesman, M. M., Fojo, T., Bates, S. E. (2002). Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Can 2:48–58.
   PubMed Web of Science ®Google Scholar
• Guillemard, V., Uri Saragovi, H. (2004). Prodrug chemotherapeutics bypass P-glycoprotein resistance and kill tumors in vivo with high efficacy and target dependent selectivity. Oncogene 23:3613–3621.
   PubMed Web of Science ®Google Scholar
• Hoffmann, J., Vitale, I., Buchmann, B., Galluzzi, L., Schwede, W., Senovilla, L., et al. (2008). Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone. Cancer Res 68:5301–5308.
   PubMed Web of Science ®Google Scholar
• Huang, Z., Waxman, D. J. (2001). Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitors. Cancer Gene Ther 8:450–458.
   PubMed Web of Science ®Google Scholar
• Hung, D. Y., Chang, P., Weiss, M., Roberts, M. S. (2001). Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process. J Pharmacol Exp Ther 297:780–789.
   PubMed Web of Science ®Google Scholar
• Hung, D. Y., Siebert, G. A., Chang, P., Roberts, M. S. (2005). Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver. Br J Pharmacol 145:57–65.
   PubMed Web of Science ®Google Scholar
• Hunt, C. A., Ropella, G. E., Yan, L., Hung, D. Y., Roberts, M. S. (2006). Physiologically based synthetic models of hepatic disposition. J Pharmacokinet Pharmacodyn 33:737–772.
   PubMed Web of Science ®Google Scholar
• Ikeguchi, M., Makino, M., Kaibara, N. (2002). Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis. Langenbecks Arch Surg 387:240–245.
   PubMed Web of Science ®Google Scholar
• Kafert-Kasting, S., Alexandrova, K., Barthold, M., Laube, B., Friedrich, G., Arseniev, L., et al. (2006). Enzyme induction in cryopreserved human hepatocyte cultures. Toxicology 220:117–125.
   PubMed Web of Science ®Google Scholar
• Kennedy, T. (1997). Managing the discovery/development interface. Drug Discov Today 2:436–444.
   Web of Science ®Google Scholar
• Kim, K. Y., Kim, S. U., Leung, P. C., Jeung, E. B., Choi, K. C. (2010). Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth. Cancer Sci 101:955–962.
   PubMed Web of Science ®Google Scholar
• Kitazono, M., Sumizawa, T., Takebayashi, Y., Chen, Z. S., Furukawa, T., Nagayama, S., et al. (1999). Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 91:1647–1653.
   PubMed Web of Science ®Google Scholar
• Krishan, A., Fitz, C. M., Andritsch, I. (1997). Drug retention, efflux, and resistance in tumor cells. Cytometry 29:279–285.
   PubMedGoogle Scholar
• Kuppens, I. E., Breedveld, P., Beijnen, J. H., Schellens, J. H. (2005). Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application. Cancer Invest 23:443–464.
   PubMed Web of Science ®Google Scholar
• Larsen, A. K., Escargueil, A. E., Skladanowski, A. (2000). Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 85:217–229.
   PubMed Web of Science ®Google Scholar
• Li, A. P. (2001). Screening for human ADME/Tox drug properties in drug discovery. Drug Discov Today 6:357–366.
   PubMed Web of Science ®Google Scholar
• Li, P., Wang, G. J., Robertson, T. A., Roberts, M. S. (2009). Liver transporters in hepatic drug disposition: an update. Curr Drug Metab 10:482–498.
   PubMed Web of Science ®Google Scholar
• Makino, K., Nakajima, T., Shikamura, M., Ito, F., Ando, S., Kochi, C., et al. (2004). Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Coll Surf B Biointerf 36:35–42.
   PubMed Web of Science ®Google Scholar
• Maraldi, N. M., Zini, N., Santi, S., Scotlandi, K., Serra, M., Baldini, N. (1999). P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells. Biol Cell 91:17–28.
   PubMed Web of Science ®Google Scholar
• Marrero Ponce, Y., Cabrera Pé,rez, M. A., Romero Zaldivar, V., González Dí,az, H., Torrens, F. (2004). A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture. J Pharm Pharm Sci 7:186–199.
   PubMed Web of Science ®Google Scholar
• Martínez-Zaguilán, R., Raghunand, N., Lynch, R. M., Bellamy, W., Martinez, G. M., Rojas, B., et al. (1999). pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. Biochem Pharmacol 57:1037–1046.
   PubMed Web of Science ®Google Scholar
• Masimirembwa, C. M., Bredberg, U., Andersson, T. B. (2003). Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges. Clin Pharmacokinet 42:515–528.
   PubMed Web of Science ®Google Scholar
• Meschini, S., Marra, M., Calcabrini, A., Monti, E., Gariboldi, M., Dolfini, E., et al. (2002). Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells. Toxicol In Vitro 16:389–398.
   PubMed Web of Science ®Google Scholar
• Michael, M., Doherty, M. M. (2005). Tumoral drug metabolism: overview and its implications for cancer therapy. J Clin Oncol 23:205–229.
   PubMed Web of Science ®Google Scholar
• Michael, M., Doherty, M. M. (2007). Drug metabolism by tumours: its nature, relevance, and therapeutic implications. Exp Opin Drug Metab Toxicol 3:783–803.
   PubMed Web of Science ®Google Scholar
• Miyoshi, Y., Ando, A., Takamura, Y., Taguchi, T., Tamaki, Y., Noguchi, S. (2002). Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues. Int J Cancer 97:129–132.
   PubMed Web of Science ®Google Scholar
• Modica-Napolitano, J. S., Aprille, J. R. (2001). Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv Drug Del Rev 49:63–70.
   PubMed Web of Science ®Google Scholar
• Molinari, A., Calcabrini, A., Meschini, S., Stringaro, A., Del Bufalo, D., Cianfriglia, M., et al. (1998). Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells. Int J Cancer 75:885–893.
   PubMed Web of Science ®Google Scholar
• Molinari, A., Calcabrini, A., Monti, E., Del Bufalo, D., Stringaro, A., Dolfini, E., et al. (2000). Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells. Int J Cancer 87:615–628.
   PubMed Web of Science ®Google Scholar
• Munteanu, E., Verdier, M., Grandjean-Forestier, F., Stenger, C., Jayat-Vignoles, C., Huet, S., et al. (2006). Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells. Biochem Pharmacol 71:1162–1174.
   PubMed Web of Science ®Google Scholar
• Murphy, M. P. (2008). Targeting lipophilic cations to mitochondria. Biochim Biophys Acta 1777:1028–1031.
   PubMed Web of Science ®Google Scholar
• Murphy, M. P., Smith, R. A. (2007). Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629–656.
   PubMed Web of Science ®Google Scholar
• Mwandumba, H. C., Russell, D. G., Nyirenda, M. H., Anderson, J., White, S. A., Molyneux, M. E., et al. (2004). Mycobacterium tuberculosis resides in nonacidified vacuoles in endocytically competent alveolar macrophages from patients with tuberculosis and HIV infection. J Immunol 172:4592–4598.
   PubMed Web of Science ®Google Scholar
• Nakata, K., Tanaka, Y., Nakano, T., Adachi, T., Tanaka, H., Kaminuma, T., et al. (2006). Nuclear receptor-mediated transcriptional regulation in phase I, II, and III xenobiotic metabolizing systems. Drug Metab Pharmacokinet 21:437–457.
   PubMed Web of Science ®Google Scholar
• Noguchi, S. (2006). Predictive factors for response to docetaxel in human breast cancers. Cancer Sci 97:813–820.
   PubMed Web of Science ®Google Scholar
• Ouar, Z., Bens, M., Vignes, C., Paulais, M., Pringel, C., Fleury, J., et al. (2003). Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells. Biochem J 370:185–193.
   PubMed Web of Science ®Google Scholar
• Paillard, D., Grellet, J., Dubois, V., Saux, M. C., Quentin, C. (2002). Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model. Antimicrob Agents Chemother 46:288–293.
   PubMed Web of Science ®Google Scholar
• Pan, M. H., Huang, T. M., Lin, J. K. (1999). Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486–494.
   PubMed Web of Science ®Google Scholar
• Pan, G. Y., Huang, Z. J., Wang, G. J., Fawcett, J. P., Liu, X. D., Zhao, X. C., et al. (2003). The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med 69:632–636.
   PubMed Web of Science ®Google Scholar
• Park, S., Yoo, H. S. (2010). In vivo and in vitro anti-cancer activities and enhanced cellular uptakes of EGF fragment decorated doxorubicin nano-aggregates. Int J Pharm 383:178–185.
   PubMed Web of Science ®Google Scholar
• Peer, D., Dekel, Y., Melikhov, D., Margalit, R. (2004). Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models. Cancer Res 64:7562–7569.
   PubMed Web of Science ®Google Scholar
• Pérez-Tomás, R. (2006). Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Curr Med Chem 13:1859–1876.
   PubMed Web of Science ®Google Scholar
• Prior, S., Gander, B., Lecaroz, C., Irache, J. M., Gamazo, C. (2004). Gentamicinloaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes. J Antimicrob Chemother 53:981–988.
   PubMed Web of Science ®Google Scholar
• Raghunand, N., Martínez-Zaguilán, R., Wright, S. H., Gillies, R. J. (1999). pH and drug resistance. II. Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol 57:1047–1058.
   PubMed Web of Science ®Google Scholar
• Rajagopal, A., Simon, S. M. (2003). Subcellular localization and activity of multidrug resistance proteins. Mol Biol Cell 14:3389–3399.
   PubMed Web of Science ®Google Scholar
• Rashid, F., Horobin, R. W. (1991). Accumulation of fluorescent non-cationic probes in mitochondria of cultured cells: observations, a proposed mechanism, and some implications. J Microsc 163:233–241.
   PubMed Web of Science ®Google Scholar
• Renard, C., Vanderhaeghe, H. J., Claes, P. J., Zenebergh, A., Tulkens, P. M. (1987). Influence of conversion of penicillin G into a basic derivative on its accumulation and subcellular localization in cultured macrophages. Antimicrob Agents Chemother 31:410–416.
   PubMed Web of Science ®Google Scholar
• Ross, M. F., Da Ros, T., Blaikie, F. H., Prime, T. A., Porteous, C. M., Severina, I. I., et al. (2006). Accumulation of lipophilic dications by mitochondria and cells. Biochem J 400:199–208.
   PubMed Web of Science ®Google Scholar
• Rottenberg, H. (1984). Membrane potential and surface potential in mitochondria: uptake and binding of lipophilic cations. J Membr Biol 81:127–138.
   PubMed Web of Science ®Google Scholar
• Roy, P., Waxman, D. J. (2006). Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer. Toxicol In Vitro 20:176–186.
   PubMed Web of Science ®Google Scholar
• Salonga, D., Danenberg, K. D., Johnson, M., Metzger, R., Groshen, S., Tsao-Wei, D. D., et al. (2000). Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 6:1322–1327.
   PubMed Web of Science ®Google Scholar
• Schellmann, N., Deckert, P. M., Bachran, D., Fuchs, H., Bachran, C. (2010). Targeted enzyme prodrug therapies. Mini Rev Med Chem 10:887–904.
   PubMed Web of Science ®Google Scholar
• Schindler, M., Grabski, S., Hoff, E., Simon, S. M. (1996). Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in Adriamycin-resistant-resistant cells (MCF-7adr). Biochemistry 35:2811–2817.
   PubMed Web of Science ®Google Scholar
• Schinkel, A. H., Jonker, J. W. (2003). Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Del Rev 55:3–29.
   PubMed Web of Science ®Google Scholar
• Schüller, J., Cassidy, J., Dumont, E., Roos, B., Durston, S., Banken, L., et al. (2000). Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 45:291–297.
   PubMed Web of Science ®Google Scholar
• Seral, C., Carryn, S., Tulkens, P. M., Van Bambeke, F. (2003). Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. J Antimicrob Chemother 51:1167–1173.
   PubMed Web of Science ®Google Scholar
• Seubert, CM, Stritzker, J, Hess, M, Donat, U, Sturm, JB, Chen, N, et al. (2011). Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a beta-galactosidase-activatable prodrug seco-analog of duocarmycin SA. Cancer Gene Ther 18:42–52.
   PubMed Web of Science ®Google Scholar
• Shen, F., Bailey, B. J., Chu, S., Bence, A. K., Xue, X., Erickson, P., et al. (2009). Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar (PSC833) in multidrug resistance human cancer cells. J Pharmacol Exp Ther 330:423–429.
   PubMed Web of Science ®Google Scholar
• Shen, F., Chu, S., Bence, A. K., Bailey, B., Xue, X., Erickson, P. A., et al. (2008). Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. J Pharmacol Exp Ther 324:95–102.
   PubMed Web of Science ®Google Scholar
• Siebert, G. A., Hung, D. Y., Chang, P., Roberts, M. S. (2004). Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs. J Pharmacol Exp Ther 308:228–235.
   PubMed Web of Science ®Google Scholar
• Singh, S. S. (2006). Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Curr Drug Metab 7:165–182.
   PubMed Web of Science ®Google Scholar
• Susa, M., Iyer, A. K., Ryu, K., Hornicek, F. J., Mankin, H., Amiji, M. M., et al. (2009). Doxorubicin loaded polymeric nanoparticulate delivery system to overcome drug resistance in osteosarcoma. BMC Cancer 9:399.
   PubMed Web of Science ®Google Scholar
• Trapp, S., Rosania, G. R., Horobin, R. W., Kornhuber, J. (2008). Quantitative modeling of selective lysosomal targeting for drug design. Eur Biophys J 37:1317–1328.
   PubMed Web of Science ®Google Scholar
• Tulkens, P. M. (1990). Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections. Scand J Infect Dis Suppl 74:209–217.
   PubMedGoogle Scholar
• Usansky, H. H., Sinko, P. J. (2005). Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a). J Pharmacol Exp Ther 314:391–399.
   PubMed Web of Science ®Google Scholar
• Van Bambeke, F., Barcia-Macay, M., Lemaire, S., Tulkens, P. M. (2006). Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr Opin Drug Discov Dev 9:218–230.
   PubMed Web of Science ®Google Scholar
• Van Bambeke, F., Carryn, S., Seral, C., Chanteux, H., Tyteca, D., Mingeot-Leclercq, M. P., Tulkens, P. M. (2004). Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages. Antimicrob Agents Chemother 48:2853–2860.
   PubMed Web of Science ®Google Scholar
• van Montfoort, J. E., Hagenbuch, B., Groothuis, G. M., Koepsell, H., Meier, P. J., Meijer, D. K. (2003). Drug uptake systems in liver and kidney. Curr Drug Metab 4:185–211.
   PubMed Web of Science ®Google Scholar
• van Zon, A., Mossink, M. H., Schoester, M., Scheper, R. J., Sonneveld, P., Wiemer, E. A. C. (2004). Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression. Cancer Res 64:4887–4892.
   PubMedGoogle Scholar
• Walko, C. M., Lindley, C. (2005). Capecitabine: a review. Clin Ther 27:23–44.
   PubMed Web of Science ®Google Scholar
• Wang, L., Zhang, D., Raghavan, N., Yao, M., Ma, L., Frost, C. A., et al. (2010). In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome p450 phenotyping, inhibition, and induction studies. Drug Metab Dispos 38:448–458.
   PubMed Web of Science ®Google Scholar
• Xiong, X. B., Ma, Z., Lai, R., Lavasanifar, A. (2010). The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Biomaterials 31:757–768.
   PubMed Web of Science ®Google Scholar
• Yang, K. Y., Lin, L. C., Tseng, T. Y., Wang, S. C., Tsai, T. H. (2007). Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 853:183–189.
   PubMed Web of Science ®Google Scholar
• Yu, Y., Liu, L., Wang, X., Liu, X., Xie, L., Wang, G. (2010). Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol 79:1000–1006.
   PubMed Web of Science ®Google Scholar
• Zhang, X., Shedden, K., Rosania, G. R. (2006). A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration. Mol Pharm 3:704–716.
   PubMedGoogle Scholar
• Zurita, A. J., Diestra, J. E., Condom, E., Garcia Del Muro, X., Scheffer, G. L., Scheper, R. J., et al. (2003). Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours. Br J Cancer 88:879–886.
   PubMed Web of Science ®Google Scholar